Interlaboratory proficiency processing scheme in CSF aliquoting: implementation and assessment based on biomarkers of Alzheimer's disease

Alzheimer's Research & Therapy
Piotr LewczukCharlotte Teunissen

Abstract

In this study, we tested to which extent possible between-center differences in standardized operating procedures (SOPs) for biobanking of cerebrospinal fluid (CSF) samples influence the homogeneity of the resulting aliquots and, consequently, the concentrations of the centrally analyzed selected Alzheimer's disease biomarkers. Proficiency processing samples (PPSs), prepared by pooling of four individual CSF samples, were sent to 10 participating centers, which were asked to perform aliquoting of the PPSs into two secondary aliquots (SAs) under their local SOPs. The resulting SAs were shipped to the central laboratory, where the concentrations of amyloid beta (Aβ) 1-42, pTau181, and albumin were measured in one run with validated routine analytical methods. Total variability of the concentrations, and its within-center and between-center components, were analyzed with hierarchical regression models. We observed neglectable variability in the concentrations of pTau181 and albumin across the centers and the aliquots. In contrast, the variability of the Aβ1-42 concentrations was much larger (overall coefficient of variation 31%), with 28% of the between-laboratory component and 10% of the within-laboratory (i.e., between-aliquot) ...Continue Reading

References

Dec 29, 2000·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·H VandersticheleE Vanmechelen
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 28, 2010·International Journal of Alzheimer's Disease·Maria BjerkeKaj Blennow
May 20, 2011·Journal of Alzheimer's Disease : JAD·Rüdiger ZimmermannPiotr Lewczuk
Oct 15, 2011·Clinical Chemistry·Therese RosenlingRainer Bischoff
Apr 13, 2012·Journal of Alzheimer's Disease : JAD·Armand Perret-LiaudetSylvain Lehmann
May 23, 2014·Lancet Neurology·Bruno DuboisJeffrey L Cummings
Jul 18, 2015·Biopreservation and Biobanking·Olga A KofanovaFay Betsou
Jul 29, 2015·Frontiers in Neurology·Maria João LeitãoCatarina Resende de Oliveira
Oct 18, 2016·Biopreservation and Biobanking·Amélie GaignauxFay Betsou
Oct 28, 2017·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Piotr LewczukUNKNOWN Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato
Jan 30, 2018·Biopreservation and Biobanking·Fay BetsouLalita Wadhwa

❮ Previous
Next ❯

Methods Mentioned

BETA
nucleic acid extraction
ELISA

Software Mentioned

Stata

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.